How to Extract the Most Value from Your Exit

Posted by John Badger on May 20, 2015 7:21:00 AM

Given today’s very active technology merger and acquisition market, which continues to look strong in 2015, it makes sense to proactively prepare to achieve the most value from your exit.

Too often, technology companies seeking a profitable exit make the flawed assumption that the due diligence and valuation process is driven solely by the buyer. This assumption can lead to fatal positioning and diligence mistakes, which undermine value, slow the evaluation process, or ultimately kill the deal. The truth is, as a selling team you have an enormous opportunity to shorten due diligence timelines and proactively repair those areas acquirers look to press their advantage, thus maximizing the value that the buyer assigns to your company.

Perhaps you’ve heard the saying that technology companies are generally bought, not sold. That’s true. The largest, most active buyers—companies like IBM, Google, Oracle, and Microsoft—are continually seeking out and evaluating emerging technology companies to expand their portfolios.

This has two important implications for the selling company:

First, you never know when a potential buyer will “knock on your door,” so your senior team should be prepared for a rapid, comprehensive due diligence process now.

Second, you need to understand the core aspects of the technology buyer’s key valuation criteria and then scrutinize your company from the buyer’s perspective, or from “outside in.”

Remember, during the due diligence process, time is not your friend; the longer the diligence process stretches out the higher the probability that concerns will arise, and purchase price adjustments will occur. Careful examination of your company from an external perspective and addressing potential buyers’ concerns in advance will not only increase the likelihood of receiving the price that was agreed to in the term sheet, but will also make the deal move faster and improve the chance of a successful outcome.

Read More

Topics: M&A

Secure File Sharing for Legal Services—5 Essential Benefits

Posted by Richard Andersen on May 18, 2015 7:21:11 AM

There may be no profession with a greater need for sharing large volumes of information than the document-centric legal world. Moreover, the process involves sharing these large volumes of documents both quickly and with meticulous attention to security. Any successful legal process—for the corporate legal department and private law firm alike—depends on the ability to effectively and securely manage critical information exchange between multiple parties.

Gone are the days when lawyers would carry sensitive legal documents in a briefcase or the trunk of their car. Just as these physical means of security were relatively easy to breach, electronic means of document sharing, including email, FTP sites and other archaic document delivery methods, have also proven to be both insecure and inefficient.

The best way to navigate today’s legal processes is to utilize a centralized cloud-based repository that is not only organized, secure, and auditable, but also provides authorized users secure and customized access from anywhere, at any time.

ShareVault provides lawyers and their clients a powerful, secure and easy-to-use online data repository that manages the exchange of critical legal documents, facilitating communication and collaboration, while also serving as a powerful tool to establish a state of readiness for key legal events. With ShareVault, law firms and in-house counsel can easily access, publish, manage and search all case-relevant documents on a 24/7 basis, as well as share them with multiple parties, including legal teams, clients, expert witnesses, litigation support vendors or anyone else who has been granted appropriate access.

ShareVault gives law firms the ability to exchange thousands of confidential documents with multiple parties in diverse locations, thus streamlining the legal process as well as reducing costs. And, because it’s equipped with powerful reporting tools and works in concert with existing document management systems such as Microsoft SharePoint, it meets litigation’s exacting compliance and risk management standards.

Read More

Topics: Information, Security

ShareVault Immune to VENOM Vulnerability

Posted by Phil Bandy on May 15, 2015 8:43:12 PM

Two days ago, the VENOM vulnerability (CVE-2015-3456) was exposed.  The ShareVault security team immediately investigated our infrastructure to confirm that the ShareVault platform and underlying infrastructure is immune to this vulnerability.

Read More

New ShareVault Software Update Adds ShareVault Reader App and Improved Document-to-Document Hyperlinking

Posted by John Badger on May 10, 2015 11:12:00 PM

Software_UpdateShareVault was updated on Sunday, May 10th, adding the following important enhancements:

  • ShareVault Reader app - The fastest way to view and print protected documents
  • Enhanced Document-to-document hyperlinking - Improved functionality for this feature that is of particular importance to applications that require sharing electronic regulary submission documents
  • Enhancements to improve email deliverability
  • Various bug fixes

The new update is now live on ShareVault, and there's nothing that you need to do to take advantage of the new enhancements.

Read More

Topics: Products, Software Update

ShareVault Attends eRegulatory and Intelligence Annual Conference

Posted by Steve Joseph on May 4, 2015 8:49:33 AM

May 11th – 13th | Philadelphia

Nobody likes regulatory compliance, but ignoring it is not an option. Failing to comply can result in a damaged reputation, loss of customers, as well as legal action. The recent upsurge of regulatory reform in response to a number of corporate scandals, as well as the global financial crisis, has multiplied the challenges and costs of managing regulatory compliance for organizations worldwide. While there are information technology (IT) and information systems (IS) tools to support regulatory compliance efforts, these tools are not always adequate to fully address the compliance needs of organizations.

Read More

Topics: Events

ShareVault Attends NewYorkBIO 25th Anniversary Conference

Posted by Steve Joseph on Apr 29, 2015 11:38:28 AM

May 4th & 5th | 2015 | New York City

ShareVault is excited to exhibit at NewYorkBIO’s 25th Anniversary Conference held at 10 on the Park at the Time Warner Center in the heart of midtown Manhattan.

For a quarter of a century, NewYorkBIO has been the voice of New York's life science community, helping to define the industry, protect its interests, and grow its opportunities.

Today, NewYorkBIO continues to commit to driving innovation and supporting the development and growth of New York State’s life science industry and the community by providing a network for information exchange, shared services and collective action. They are the leading advocate for the bioscience industry in New York State.

The NewYorkBIO 25th Anniversary Conference will attract more than 650 attendees from 13 states and 7 countries. Of the attendees, 27 are company CEOs, while more than 65% hold management, director, C-level or executive management positions.

Read More

Topics: Events

The Virtues of the Virtual Biotech

Posted by Ally van den Herik on Apr 27, 2015 7:51:01 AM

How many people does it take to run a successful biotech company?

The traditional model of the biotech company in the glass-fronted building with a sparkling fountain out front and employing a hundred or more scientists working on a long pipeline of assets may be on the way out.

The central investment case for such a model was that a team of that kind, once assembled, could find and develop multiple assets that could be sold to big pharmaceutical companies. The key word was “multiple” because no single asset could justify the vast cash infusion that this type of model demands.

But judging by Janssen Pharmaceuticals’ recent purchase of British Firm XO1 in March, that model, at least in some cases, may be changing.

So how many people does it take to run a successful biotech company? In the case of XO1, it appears that maybe as few as two. Founded in April 2013, XO1 is a virtual, asset-centric drug development company, “staffed” by senior leaders focused on the discovery and development of innovative pharmaceuticals.

Read More

Topics: Information, Life Sciences

Tom Brokaw to Deliver Keynote at 2015 BIO International Convention

Posted by Steve Joseph on Apr 23, 2015 12:17:00 PM

June 15-18, 2015 | Philadelphia

Recently we published a blog post called 10 Reasons to Attend BIO International Convention, but here's another great one: Veteran journalist and author Tom Brokaw will deliver a keynote address at a Tuesday luncheon (12-1:30) at the Pennsylvania Convention Center.

The BIO International Convention draws more than 15,000 leaders from the biopharmaceutical industry each year and provides a myriad of opportunities for networking, partnering and seeking licensing deals.

Tom Brokaw, a journalistic icon whose trusted insights have changed the way we think about the world, has traveled the globe to cover elections, summits, political turmoil, war, and major news stories of every description. Even after stepping aside from two decades at the helm of NBC Nightly News, Tom Brokaw is now more engaged than ever in finding stories that show the strength, perseverance and 

courage of people not only here at home, but around the globe. From the turmoil of the Vietnam War and the fall of the Berlin Wall to the war zones of Iraq and Afghanistan and the hallowed ground of Normandy, where he interviewed President Obama during the anniversary commemoration of D-Day, Brokaw has the journalistic acumen and global experience to help us make sense of the complex stories of our times.

Register for the conference before April 23 for early bird discounts.

Read More

Topics: Information, Life Sciences, Events

8 Reasons to Attend the 2nd Due Diligence Summit for Life Sciences

Posted by Steve Joseph on Apr 22, 2015 12:08:00 PM

JUNE 9-10 | BOSTON | ExL Events

Competition is fierce in today’s Life Sciences industry, making it more important than ever to perform due diligence that is both thorough and effective.

As the only Life Science educational event dedicated to due diligence, the 2nd Due Diligence Summit For Life Sciences, presented by ExL Events, focuses on running a tight ship throughout the due diligence process. During the summit, experts from a variety of pharmaceutical companies will discuss why success in today’s market can depend heavily on having a well-defined business development plan, which includes acquisitions and in-licensing strategies and well as understanding which products, drugs and companies they should focus on acquiring.

Comprehensive due diligence is a key component in measuring the profitability and efficacy of a potential product. It also helps to mitigate the risks that come from taking on a new product, portfolio or company, as well as facilitate the negotiation of a mutually beneficial contract and ensure regulatory compliance.

Read More

Topics: Life Sciences, Events, Partnerships

Prepare for Success at the BIO International Convention by Attending These Classes

Posted by Steve Joseph on Apr 20, 2015 8:09:00 AM

If you’re planning to attend the BIO International Convention in Philadelphia (June 15th – 18th) this year you might consider arriving a couple days early to take advantage of one of two courses that BIO is offering to help attendees maximize the value and success of the time they spend at the convention.

The courses are held in the same location as the BIO International Convention, but take place on Saturday and Sunday and continue on Monday when the convention begins.

The two coinciding courses are designed to prepare and support the attendees of the conference who are focused on making deals, seeking investors or partners, or raising venture capital during the convention. The courses are taught by experienced business development professionals from leading pharmaceutical and biotechnology firms, and experts from the fields of law and public relations. All of the instructors have deep hands-on experience with doing deals and negotiating licensing agreements in the biotech industry.

Read More

Topics: Life Sciences, Events, Partnerships

About ShareVault

Simple & Secure Document Sharing

ShareVault offers virtual data rooms for securely sharing documents with third parties. Typically used to share due diligence documents during M&A, partnering, fundraising and other dealmaking scenarios, ShareVault is increasingly being used for a wide variety of other applications, primarily in highly regulated industries, for securely sharing documents with third parties. ShareVault can be set up and deployed in an hour, yet offers enterprise-grade security and scaleability.

Learn More About Sharing Documents Simply and Securely Using ShareVault

Subscribe to Email Updates